An Orally Active Chemokine Receptor CCR2 Antagonist Prevents Glomerulosclerosis and Renal Failure in Type 2 Diabetes
Kidney International - United States
doi 10.1038/ki.2011.102
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 1, 2011
Authors
Publisher
Elsevier BV